Anthony Molloy's most recent trade in Pacira BioSciences Inc was a trade of 4,521 Common Stock done at an average price of $38.6 . Disclosure was reported to the exchange on June 5, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 38.55 per share. | 05 Jun 2023 | 4,521 | 12,877 (0%) | 0% | 38.6 | 174,285 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 05 Jun 2023 | 2,267 | 17,398 (0%) | 0% | 38.3 | 86,774 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 38.31 per share. | 04 Jan 2023 | 546 | 19,450 (0%) | 0% | 38.3 | 20,917 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 39.09 per share. | 04 Jan 2023 | 158 | 19,996 (0%) | 0% | 39.1 | 6,177 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 19,900 | 19,900 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 7,950 | 19,950 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 2,980 | 14,570 (0%) | 0% | 61.4 | 182,895 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 60.40 per share. | 06 Jun 2022 | 1,830 | 12,000 (0%) | 0% | 60.4 | 110,532 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 59.38 per share. | 06 Jun 2022 | 740 | 13,830 (0%) | 0% | 59.4 | 43,941 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 76.03 per share. | 06 Apr 2022 | 16,060 | 23,990 (0%) | 0% | 76.0 | 1,221,042 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2022 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 44.20 per share. | 06 Apr 2022 | 10,000 | 30,550 (0%) | 0% | 44.2 | 442,000 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2022 | 7,000 | 1,750 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.35 per share. | 06 Apr 2022 | 7,000 | 40,050 (0%) | 0% | 38.4 | 268,450 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 77.03 per share. | 06 Apr 2022 | 3,937 | 20,053 (0%) | 0% | 77.0 | 303,267 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2022 | 3,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.34 per share. | 06 Apr 2022 | 3,000 | 20,550 (0%) | 0% | 40.3 | 121,020 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 77.94 per share. | 06 Apr 2022 | 2,503 | 17,550 (0%) | 0% | 77.9 | 195,084 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2022 | 2,500 | 625 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.38 per share. | 06 Apr 2022 | 2,500 | 33,050 (0%) | 0% | 34.4 | 85,938 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Sale of securities on an exchange or to another person at price $ 63.55 per share. | 18 Jan 2022 | 224 | 17,550 (0%) | 0% | 63.5 | 14,235 | Common Stock |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Anthony Molloy | Chief Lgl & Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2022 | 2,000 | 17,774 (0%) | 0% | 0 | Common Stock |